2Jensen KT,Carstens J,Pedersen EB.Effect of BNP on renal hemodynamics,tubular function and vasoacfive hormones in humans.Am J Physiol,1998,274:63-72.
3Toru S,Kazuhide Y,Osamu N,et al.Screening for cardiac dysfunction in asymptomatie patients by measuring B-type natriuretie peptide levels.Jpn Heart J,2000,41:205-214.
4MeDouagh TA,Robb SD,Murdoch DR,et al.Biochemical detection of left ventricular systolic dysfunction.Lancet,1998,351(9095):9-13.
5Dao Q,Krishnaswamy P,Kazanegra R,et al.Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent care setting.J Am Coil C.ardinl,2001,37:379-385.
6MeNairy M,Gardetto N,Clopton P,et al.Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure:Implication for outpalient mornitoring with B-type natriuretie pepfide.Am Heart J,2002,143:406-411.
8Btteneourt P,Ferreira A,Dias P,et al.Evaluation of brain natriuretie peptide in diagnosis of heart failure.Cardiology,2000,93:19-25.
9Harrison A,Morrison LK,Krishnaswamy P,et al.B-natriuretie peptide prediels future cardiac erents in patients presenting to the emergency with dyspnea.Ann Emerg Med,2002,39:131-138.
10Berger R,Huelsman M,Strecker K,et al.B-natrittretic peptide preddiets sudden in patients with chronic hear failure.Circulation,2002,105:2392-2397.
2de Lemos JA, Marrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med, 2001,345:1014-1021.
3Morrow DA, de Lemos JA, Sabatine MS, et al. Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non -ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18. J Am Coll Cardiol, 2003,41:1264-1272.
4Tulevski II, Mulder BJ, van-Veldhuisen DJ. Utility of a BNP as a marker for RV dysfunction in acute pulmonary embolism. J Am Coll Cardiol, 2002, 39(12): 2080.
5Maisel A. B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure. J Card Fail, 2001, 7(2): 183-193.
6aeda K, Tsutamoto T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J, 1998, 135(5 Pt 1): 825-832.
7Troughton RW, Frampton CM, Yandle TG, et al. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet, 2000, 355(9210): 1126-1130.
8Kawai K, Hata K, Takaoka H, et al. Plasma brain natriuretic peptide as a novel therapeutic indicator in idiopathic dilated cardiomyopathy during beta-blocker therapy: a potential of hormone-guided treatment. Am Heart, 2001, 141(6): 925-932.
9Morita E, Yasue H, Yoshimura M, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation, 1993, 88(1): 82-91.
10de-Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med, 2001, 345(14): 1014-1021.
1Maeda K,Tsutamota T, Wada A, et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular enddiastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J, 1998, 135:825.
2Berdageu P, Caffin PY, Barazer I, et al. Use of N-termi-nalprohormone-brain natriuretic peptide assay foretiologic diagno sisofacute dyspnea inelderly patients. Am Heart J ,2006,151:690-698.
3Villaeorta H,Duarte A,Duartc NM,et al. The role of B · type natriuretie peptidc in the diagnosis of congestive heart failure in patients presenting to an emergency department wilh dyspnea. Arq Bras Cardiol, 2002,79 : 569-572.
4Morrisonl K, Harrison A,Krishnaswamy P,et al. Utilityof a rapid β-natri- uretie peptide assay in diferentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol,2002,39: 202.
5[1]Schultz M,Faber J,Kistorp C,et al.N-terminal pro-B-type natriuretic peptide (NT-pro-BNP) in different thyroid function states[J].Clin Endocrinol (Oxf),2004,60 (1):54-59.
6[2]McCullough PA,Sandberg KR.Sorting out the evidence on natriuretic peptides[J].Rev Cardiovasc Med,2003,4(Supp 4):S13-19.
7[4]Pemberton C,Johnson M,Yandle T,et al.Deconvolution analysis of cardiac natriuretic peptides during acute volume overload[J].Hypertension,2001,36:355-359.
8[5]Kohno M,Horio T,Yasunari K,et al.Stimulation of brain natriuretic pep tide release from the heart by thyroid hormone[J].Metabolism,1993,42(8):1059-1064.
9[6]Liang F,Webb P,Marimuthu A,et al.Triiodothyronine increases brain natriuretic peptide (BNP) gene transcription and amplifies endotheia-dependent BNP gene transcription and hypertrophy in neonatal rat ventricularmyocytes[J].J Biol Chem,2003,278(17):15073-15083.
10[7]Klein I,Ojamaa K.Thyroid hormone and the cardiovascular system[J].New England Journal of Medicine,2001,344:501-509.
